Funded Tech Companies
Osivax
Researching who provided funding to Osivax? Meiji joined the equity holders in this innovative biopharmaceutical company.
Company Overview
Company Name
Osivax
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
?70 Rue Saint Jean Dieu
Lyon, 69007
France
Lyon, 69007
France
Phone
Website
Email Address
Company Background Information
Overview
Osivax is a clinical-stage biotechnology company developing a transformative pipeline of universal vaccines uniquely designed to leverage both arms of the immune system: superior T-cell immune responses generated by its proprietary oligoDOM® technology, and B-cell responses brought by conventional vaccines. Osivax' mission is to develop universal vaccine candidates designed to provide protection against viruses that mutate rapidly, starting with influenza and rapidly expanding to other areas such as sarbecovirus.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/4/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Alexandre Le Vert
Chief Medical Officer
Nicola Groth
Chief Technical Officer
Vincent Bille
VP - Bus. Development
Delphine Guyon-Gellin
VP - Bus. Development
Florence Nicolas
VP - Finance
Florian Sourd
VP - Regulatory Affairs
Linda Lebon
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs